Patent AnalyticsExaminers
Rankings

Law firm or agent

GOODWIN PROCTER LLP

6,233 applicationsfiled 2006 to 2026

Allowance rate
61%
−14 pts vs the USPTO range 60% to 62%
Rejections before allowance
1.6
level with the USPTO
Months to first action
16.5 mo
−2.1 vs the USPTO
Needed an RCE
29%
+2 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations1,606 apps
C07D Heterocyclic compounds503 apps
C07K Peptides402 apps
G06F Electric digital data processing334 apps
G06Q Data processing for administrative, commercial, financial purposes289 apps
A61B Diagnosis, surgery, identification285 apps

Art units

OPAP359 apps
1625196 apps
1624191 apps
1627159 apps
1628145 apps
1626140 apps

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19882373COMPOUNDS FOR LYSOSOMAL DEGRADATION OF TARGET PROTEINS2026-10-05Pending00n/a
19881761MULTI-SPECIFIC ANTIGEN-BINDING PROTEINS WHICH BIND HUMAN FIBRIN YC OR FIBRINOGEN YC…2026-10-02Pending00n/a
19882129ANTI-CLDN6 ANTIBODY, ANTIBODY-DRUG CONJUGATE COMPRISING SAME AND MEDICAL USE THEREOF2026-10-02Pending00n/a
15394081Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15531043Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15789837Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15577848Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15672486Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15543527Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15778210Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 6,233 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in